The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy

P. Fouqueray, V. Pirags, S.E. Inzucchi, C.J. Bailey, G. Schernthaner, M. Diamant, H.E. Lebovitz

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)565-568
JournalDiabetes Care
Issue number3
Publication statusPublished - 2013

Cite this